• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal

The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • expand Nexium capsules Clinical Experience Investigation
    Study Id
    D961HC00010
    Disease
    gastroenterology
    Drug Name
    Nexium, esomeprazole
    Study Name
    D961HC00010
    Recruiting Status
    Open
    Protocol
    Apr 29, 2013
    • D961HC00010 (240 KB)
    Report Status
    Not Available
  • expand Drug utilization and safety events among children using esomeprazole, other proton pump inhibitors or H2-receptor antagonists
    Study Id
    D9612N00016
    Disease
    gastroesophageal reflux disease
    Drug Name
    Nexium
    Study Name
    D9612N00016
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Nexium capsules Hp Specific Clinical Experience Investigation
    Study Id
    D961HC00011
    Disease
    gastrointestinal diseases
    Drug Name
    Nexium
    Study Name
    D961HC00011
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand European Real Life Study on NSAIDs Treated Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS): Assessment of Pain Relieve, Gastrointestinal (GI) Symptoms, Adherence and Health Resource Consumption
    Study Id
    NIS-GEU-DUM-2010/1
    Disease
    osteoarthritis
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GEU-DUM-2010/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Aug 3, 2012
    • NIS-GEU-DUM-2010-1.pdf (500 KB)
  • expand Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
    Study Id
    NIS-GRU-NEX-2009/2
    Disease
    gastrointestinal bleeding
    Drug Name
    Nexium
    Study Name
    NIS-GRU-NEX-2009/2
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Feb 24, 2012
    • NIS-GRU-NEX-2009_2.pdf (405 KB)
  • expand A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease (CD) in Japan
    Study Id
    D9423C00001
    Disease
    Crohn's disease
    Drug Name
    Entocort capsules
    Study Name
    D9423C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand National Survey on GERD Patients (Adults and Children)
    Study Id
    NIS-GFR-DUM-2008/2
    Disease
    acid reflux
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GFR-DUM-2008/2
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Sep 14, 2010
    • NIS-GFR-DUM-2008_2.pdf (259 KB)
  • expand Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
    Study Id
    NIS-GKR-ATC-2011/1
    Disease
    gastroesophageal reflux disease
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GKR-ATC-2011/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Bioequivalence Study Comparing a Pellets Based Sachet Formulation of D961H 20 mg and a Commercial HPMC Capsule of D961H 20 mg After Repeated Oral Administration in Japanese Healthy Male Subjects.
    Study Id
    D961TC00001
    Disease
    bioequivalence
    Drug Name
    esomeprazole
    Study Name
    D961TC00001
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Observational Study to Evaluate Helicobacter Pylori Susceptibility to Clarithromycin and to Estimate Eradication and Healing Rates of Duodenal Ulcer Routine Eradication Therapy at the End of Treatment and 52 Weeks From the Therapy Start
    Study Id
    NIS-GRU-NEX-2009/1
    Disease
    duodenal ulcer
    Drug Name
    Nexium
    Study Name
    NIS-GRU-NEX-2009/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013